Three French laboratories condemned by brain tumors .They are attributed
In the case, which is considered unprecedented in France, three laboratories have been condemned today for the brain tumors attributed to the brain tumors attributed to Androkur to the brain tumors attributed to the Androre.
“The court has announced the responsibility of Bayer Healthcare, Sandoz and Wiststris Sante for damaged damage,” said the Poetiers Civil Court judges, who also denied the doctor and the pharmacist.
According to the complainant’s lawyer Romain Syntes, this decision paves the way “Process Multiply” Like this.
The 55 -year -year -old has taken an Androkur hormonal drug shadow for more than 20 years, which is prescribed to the treatment of hyperpelocity and endometriosis.
Since 2013, Has developed multiple Menningiomas, That is, benign tumors of layers around the brain can cause severe nervous defects.
A. The patient is currently suffering from visual disturbances, memory and extreme fatigue In 2008, a scientific article was referred to as an active ingredient (ciproterone acetate) and the development of meningiomas, which ensures that it would never be notified of the risks associated with Drug Shada.
The cause relationship is confirmed in 2018 and according to the court, “The damage from the treatments followed is effectively result” By the patient.
During the hearing in April, the pharmacist Bayer said that the patient had only taken Androkur until 2004, Then normal.
However, the judges conclude that the bayer “Users of Androkur, not taking all necessary steps to ensure quick and effective information with current or old users”Violating information task.
In the case of Vietris that produces the general version of Drug Shadam, the court has considered it “It has not made the right attempts since 2008 and allowed to know the danger of Menningiomas associated with the long intake of Drug Shadha for consumers since 2011.”. The same is assessed for Sandoz Pharmacist.
OS 97% of laboratories are responsible for the total compensation, In about 325 thousand euros, to pay the doctor and pharmacist jointly and hereditary, 25% of this amount is required with immediate effects.
For the complainant’s lawyer, it is so far “This type of first decision in France” And represented “The medical community is identifying the information failure.”
“Although the laboratories have told us, they have ways to warn of serious, stopping and irreparable side effects, they know since 2008,” Sintes told France Press.
